Broker Recommendations
Friday broker round-up
Greencore Group: Berenberg reiterates buy with a target price of 200. 0p.
Liberum lowers target price on Fuller, Smith and Turner
Analysts at Liberum lowered their target price on pub landlord Fuller, Smith and Turner from 820. 0p to 700. 0p on Friday, stating London was likely to drag on the group's recovery efforts.
Berenberg raises target price on 'conviction buy' Ceres
Analysts at Berenberg raised their target price on clean energy technology group Ceres Power from 470. 0p to 580. 0p on Friday, stating that they remained "conviction buyers" of the stock.
Canaccord upgrades Taylor Wimpey to 'buy', expects special dividends to resume in 2022
Analysts at Canaccord Genuity upgraded their recommendation for shares of Taylor Wimpey from 'hold' to 'buy' following recent share price falls despite the group's "strong" balance sheet.
Thursday broker round-up
Tullow Oil: Berenberg downgrades to hold with a target price of 40. 0p.
Hastings 'an attractive proposition' for Sampo, says Berenberg
Insurer Hastings was on the rise for the second day running after confirming late on Wednesday that it had been approached by a consortium led by Finnish insurer Sampo and its biggest shareholder, Rand Merchant Investment Holdings, about a possible cash offer.
Liberum raises target price on Hipgnosis Songs Fund
Analysts at Liberum slightly raised their target price on intellectual property investor Hipgnosis Songs Fund from 116p to 130p on Thursday, stating the group was in the right place at the right time.
Liberum raises target price on 'underappreciated' PureTech Health
Analysts at Liberum raised their target price on biotechnology company PureTech Health from 450. 0p to 490. 0p on Wednesday, stating the firm had made some "underappreciated" progress.
Canaccord Genuity says 'buy' Petropavlovsk, despite boardroom battle
Analysts at Canaccord Genuity stuck to their 'buy' recommendation for shares of Petropavlovsk despite what some market commentary said was an ongoing board battle for control of the Russian gold miner.
Berenberg cuts target price on Relx
Analysts at Berenberg lowered their target price on 'hold' rated publisher Relx from 2,080. 0p to 1,800. 0p on Wednesday, stating they were still "on the fence" about the group.
Wednesday broker round-up
Sanne: RBC Capital Markets reiterates sector performer with a target price of 600. 0p.
Jefferies ups Centrica to 'buy' following H1 update
Analysts at Jefferies upgraded energy services and solutions company Centrica's shares to 'buy' on Tuesday, stating the group now appeared to be "taking back control".
Tuesday broker round-up
Renishaw: Morgan Stanley downgrades to equal weight with a target price of 4,500. 0p.
Goldman lifts 12-month gold price forecast to $2,300
Goldman Sachs bumped up its gold price forecast on Tuesday, highlighting concerns around the longevity of the US dollar as a reserve currency.
Barclays upgrades BT to ‘equalweight’
Barclays lifted its stance on BT to ‘equalweight’ from ‘underweight’ on Tuesday, upping the price target to 130p from 115p as it said Openreach’s plans to build fibre-to-the-premises for 20 million homes over the next five to 10 years will be a positive.
Berenberg raises target price on Fevertree
Analysts at Berenberg raised their target price on drinks maker Fevertree 's shares from 2,250. 0p to 2,350. 0p on Tuesday after the group managed to consistently achieve "impressive" off-trade sales growth since the pre-lockdown stockpiling period.
Canaccord Genuity upgrades FirstGroup to 'buy'
Analysts at Canaccord Genuity upgraded their stance on transport operator FirstGroup from 'hold' to 'buy' on Monday but noted that timing remained uncertain despite the firm's good value.
Indivior surges again as Jefferies, Citi upgrade after $600m settlement
Indivior surged on Monday as Jefferies and Citi upgraded their ratings on the stock after the company reached a settlement with US authorities related to its opioid addiction treatment Suboxone.
Berenberg raises target price on Tate & Lyle
Analysts at Berenberg slightly raised their target price on 'hold' rated food ingredients manufacturer Tate & Lyle on Monday, stating the group's first-quarter update was "sweeter than expected".